Research and Markets: Global 3D Bioprinting Market 2014-2018: 3D Systems, EnvisionTEC, Organovo Holdings & Stratasys Dominate the Industry
[ Back ]   [ More News ]   [ Home ]
Research and Markets: Global 3D Bioprinting Market 2014-2018: 3D Systems, EnvisionTEC, Organovo Holdings & Stratasys Dominate the Industry

DUBLIN — (BUSINESS WIRE) — September 15, 2014Research and Markets ( http://www.researchandmarkets.com/research/sf36dc/global_3d) has announced the addition of the "Global 3D Bioprinting Market 2014-2018" report to their offering.

The Global 3D Bioprinting market to grow at a CAGR of 14.52% over the period 2013-2018

3D bioprinting is a process to produce tissues in a variety of formats from micro-scale tissues to standard multi-well tissues, where cell function and viability are preserved within the printed construct. A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells. The 3D micro-engineered environments open new channels for drug screening and fundamental studies of wound healing, angiogenesis, and stem-cell niches. Many industries have already benefitted from multiple advancements in this field, resulting in improved and more efficient processes worldwide.

The Global 3D Bioprinting market shows immense potential to grow rapidly in the future, mainly because of the advances in technology of the product. Technological advancements and innovations in the Healthcare industry have resulted in the development of equipment with up-to-date technology that is customized to the needs of patients.

According to the report, growing demand from the drug discovery process is one of the major drivers in the market. The use of 3D bioprinting reduces the risk of drug failure during pre-clinical trial testing and minimizes the complications related to human trials.

Further, the report states that one of the major challenges in the market is the high price of 3D bioprinting surgeries. The high cost of 3D printing lowers its acceptance among end-users. In addition, there is no healthcare support for 3D printing surgery, which makes it very difficult for many patients to opt for it.

The Global 3D Bioprinting market can be segmented into the technology available in the market:

Key Vendors

Prominent Vendors

Key Topics Covered:

  1. Executive Summary
  2. List of Abbreviations
  3. Scope of the Report
  4. Market Research Methodology
  5. Introduction
  6. Market Landscape
  7. Market Segmentation by Technology
  8. Geographical Segmentation
  9. Buying Criteria
  10. Market Growth Drivers
  11. Drivers and their Impact
  12. Market Challenges
  13. Impact of Drivers and Challenges
  14. Market Trends
  15. Trends and their Impact
  16. Vendor Landscape
  17. Key Vendor Analysis

For more information visit http://www.researchandmarkets.com/research/sf36dc/global_3d



Contact:

Research and Markets
Laura Wood, Senior Manager
Email Contact
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices